• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者报告结局的中心间差异低于类风湿关节炎客观活动指标:一项横断面研究。

Intercentre variance in patient reported outcomes is lower than objective rheumatoid arthritis activity measures: a cross-sectional study.

作者信息

Khan Nasim Ahmed, Spencer Horace Jack, Nikiphorou Elena, Naranjo Antonio, Alten Rieki, Chirieac Rodica M, Drosos Alexandros A, Géher Pál, Inanc Nevsun, Kerzberg Eduardo, Ancuta Codrina Mihaela, Müller Rüediger, Ørnbjerg Lykke, Sokka Tuulliki

机构信息

Division of Rheumatology, University of Arkansas for Medical Sciences.

Central Arkansas Veterans Healthcare System.

出版信息

Rheumatology (Oxford). 2017 Aug 1;56(8):1395-1400. doi: 10.1093/rheumatology/kex076.

DOI:10.1093/rheumatology/kex076
PMID:28575509
Abstract

OBJECTIVE

To assess intercentre variability in the ACR core set measures, DAS28 based on three variables (DAS28v3) and Routine Assessment of Patient Index Data 3 in a multinational study.

METHODS

Seven thousand and twenty-three patients were recruited (84 centres; 30 countries) using a standard protocol in the Quantitative Standard Monitoring of Patients with RA study. Analysis of variance (ANOVA) and mixed-effect analysis of covariance models were used to model the relationship between study centre and different patient-reported and physician-reported RA activity measures. These models were built to adjust for the remaining ACR core set measure (for each ACR core set measure or each composite index), socio-demographics and medical characteristics. ANOVA and analysis of covariance models yielded similar results, and ANOVA tables were used to present variance attributable to recruiting centre.

RESULTS

The proportion of variances attributable to recruiting centre was lower for patient reported outcomes (PROs: pain, HAQ, patient global) compared with objective measures (joint counts, ESR, physician global) in all models. In the full model, variance in PROs attributable to recruiting centre ranged from 1.53% for patient global to 3.71% for HAQ compared with objective measures that ranged from 5.92% for physician global to 9.25% for ESR; and was lower for Routine Assessment of Patient Index Data 3 (2.6%) compared with DAS28v3 (11.75%).

CONCLUSION

Intercentre variability in PROs is lower than objective measures of RA activity demonstrating that PROs may be more comparable across centres, and the need for standardization of objective measures.

摘要

目的

在一项跨国研究中评估美国风湿病学会(ACR)核心指标、基于三个变量的28关节疾病活动评分(DAS28v3)以及患者指数数据3常规评估(RAPID3)的中心间变异性。

方法

在类风湿关节炎患者定量标准监测研究中,采用标准方案招募了7023例患者(84个中心;30个国家)。使用方差分析(ANOVA)和协方差模型的混合效应分析来模拟研究中心与不同的患者报告和医生报告的类风湿关节炎活动指标之间的关系。构建这些模型以调整其余的ACR核心指标(针对每个ACR核心指标或每个综合指数)、社会人口统计学和医学特征。ANOVA和协方差模型得出了相似的结果,并且使用ANOVA表来呈现归因于招募中心的方差。

结果

在所有模型中,与客观指标(关节计数、红细胞沉降率、医生整体评估)相比,患者报告结局(PROs:疼痛、健康评估问卷、患者整体评估)归因于招募中心的方差比例更低。在完整模型中,PROs归因于招募中心的方差范围从患者整体评估的1.53%到健康评估问卷的3.71%,而客观指标的方差范围从医生整体评估的5.92%到红细胞沉降率的9.25%;并且患者指数数据3常规评估(2.6%)的方差低于DAS28v3(11.75%)。

结论

PROs的中心间变异性低于类风湿关节炎活动的客观指标,这表明PROs在各中心之间可能更具可比性,并且客观指标需要标准化。

相似文献

1
Intercentre variance in patient reported outcomes is lower than objective rheumatoid arthritis activity measures: a cross-sectional study.患者报告结局的中心间差异低于类风湿关节炎客观活动指标:一项横断面研究。
Rheumatology (Oxford). 2017 Aug 1;56(8):1395-1400. doi: 10.1093/rheumatology/kex076.
2
Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.类风湿关节炎中,巴瑞替尼与安慰剂或阿达木单抗对比的3期研究的患者报告结局:RA-BEAM研究的二次分析
Ann Rheum Dis. 2017 Nov;76(11):1853-1861. doi: 10.1136/annrheumdis-2017-211259. Epub 2017 Aug 10.
3
Relative importance of doctor-reported outcomes vs patient-reported outcomes in DMARD intensification for rheumatoid arthritis: the DUO study.医生报告的结局与患者报告的结局在类风湿关节炎改善病情抗风湿药强化治疗中的相对重要性:DUO 研究。
Rheumatology (Oxford). 2013 Feb;52(2):391-9. doi: 10.1093/rheumatology/kes285. Epub 2012 Oct 25.
4
An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.在一项类风湿性关节炎临床试验中,由三个核心数据集患者问卷测量指标组成的一个指数,与美国风湿病学会20%反应标准(ACR20)或疾病活动评分(DAS)一样,能有效地区分积极治疗与安慰剂治疗的疗效。
Arthritis Rheum. 2003 Mar;48(3):625-30. doi: 10.1002/art.10824.
5
Performance of patient-reported outcomes in the assessment of rheumatoid arthritis disease activity:the experience of the ESPOIR cohort.患者报告结局在类风湿关节炎疾病活动评估中的表现:ESPOIR队列研究经验
Clin Exp Rheumatol. 2016 Jul-Aug;34(4):646-54. Epub 2016 Jun 22.
6
Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.类风湿关节炎患者的足部活动性滑膜炎:应用疾病活动度和缓解的临床标准可能会导致对足部关节受累情况的低估。
Arthritis Rheum. 2012 May;64(5):1316-22. doi: 10.1002/art.33506.
7
An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures.在两项阿巴西普临床试验中,仅采用患者报告的结局指标的一个指数——患者指数数据3常规评估(RAPID3):结果与疾病活动评分(DAS28)以及其他包含医生报告指标的RAPID指数相似。
Rheumatology (Oxford). 2008 Mar;47(3):345-9. doi: 10.1093/rheumatology/kem364. Epub 2008 Jan 31.
8
Comparison of the Recent-Onset Arthritis Disability questionnaire with the Health Assessment Questionnaire disability index in patients with rheumatoid arthritis.近期发作关节炎残疾问卷与健康评估问卷残疾指数在类风湿关节炎患者中的比较。
Clin Exp Rheumatol. 2010 Nov-Dec;28(6):855-65. Epub 2011 Jan 3.
9
Patient-reported outcomes as predictors of remission in early rheumatoid arthritis patients treated with tight control treat-to-target approach.患者报告结局作为采用严格控制达标治疗方法治疗的早期类风湿关节炎患者缓解的预测指标。
Rheumatol Int. 2017 May;37(5):825-830. doi: 10.1007/s00296-017-3692-7. Epub 2017 Mar 13.
10
Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents.在5种药物的临床试验的9项比较中,类风湿性关节炎核心数据集的7项指标区分活性治疗与对照治疗的相对效率。
Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-47-54. Epub 2014 Oct 30.

引用本文的文献

1
Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?检测不同的患者总体评估阈值在类风湿关节炎缓解定义中的应用:当前的 ACR/EULAR 二分类标准是否最优?
Ann Rheum Dis. 2020 Apr;79(4):445-452. doi: 10.1136/annrheumdis-2019-216529. Epub 2020 Feb 5.
2
Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations.类风湿关节炎疾病活动度的常见评估在不同人群中得出不一致的分类。
Front Med (Lausanne). 2018 Mar 8;5:40. doi: 10.3389/fmed.2018.00040. eCollection 2018.